Valued at USD 98.77 billion in 2025, the vitamin K2 market is projected to reach USD 102.98 billion in 2026 and USD 145.62 billion by 2034, growing at a CAGR of 4.4% during the forecast period 2026–2034. Expansion of the food industry and the rising popularity of natural supplements drive this outlook, with bone health supplements and functional foods and beverages emerging as core demand channels. Key players including NattoPharma, Kappa Bioscience, DSM Nutritional Products, and Gnosis by Lesaffre are shaping competition through product innovation and partnerships.

Understanding the Vitamin K2 Market

Vitamin K2 is a fat-soluble vitamin essential for bone health, cardiovascular function, and blood clotting. It activates proteins that direct calcium to bones and teeth while preventing buildup in the arteries. The vitamin exists in two primary forms, MK-4 and MK-7, and occurs naturally in natto (fermented soybeans), certain cheeses, and animal-based products. Technological advancements in manufacturing processes and the growing integration of vitamin K2 in personal care products are also contributing to market expansion.

Bone Health Demand Anchors Growth

Rising awareness of bone density and of conditions such as osteoporosis is steering consumers toward vitamin K2 as an essential nutrient. A National Osteoporosis Foundation study cited in the report indicates that osteoporosis affects 10 million Americans, with an additional 44 million at risk, creating a substantial base for bone health supplements. The effect is especially significant in aging populations, where osteoporosis is more prevalent. K2 is widely incorporated into bone health supplements, frequently alongside vitamin D and calcium, targeting post-menopausal women and older adults.

Browse insights:

https://www.polarismarketresearch.com/industry-analysis/vitamin-k2-market

Product Type and Source Insights

By product type, the vitamin K2 market is segmented into MK-4 and combination drugs and MK-7 drugs. The MK-7 drugs segment holds the larger share owing to superior bioavailability and a longer half-life, which allows less frequent dosing, and it is also registering the highest growth. MK-4 is more commonly used in combination drugs and therapeutic treatments, particularly higher dosages for osteoporosis and certain heart conditions.

By source, the natural segment holds the larger share and is registering the highest growth. Natural vitamin K2, typically derived from natto, cheeses, and fermented soy products, aligns with organic and clean-label trends. Demand for plant-based vitamin K2, derived from sources such as natto or chickpeas, is rising among vegetarians and vegans. The report cites the Plant Based Foods Association, noting that the U.S. plant-based food market grew by 27% in 2020. Manufacturers are expanding their natural vitamin K2 offerings as demand for natural and minimally processed ingredients gains traction. Synthetic vitamin K2 is growing more slowly but retains a presence in pharmaceutical applications where cost-efficiency and mass production are prioritized.

Functional Foods and Beverages Broaden Reach

Manufacturers are incorporating vitamin K2 into dairy alternatives, fortified snacks, smoothies, and juices, in line with the broader functional food movement. Integration into functional foods and beverages serves consumers seeking benefits beyond basic nutrition. The powder form is registering the highest growth in smoothies, energy bars, and fortified beverages, while oil is growing steadily in nutraceutical and personal care uses. By application, the nutraceutical segment is registering the highest growth, while food and pharmaceutical holds the larger share.

Regional and Competitive Landscape

North America holds the largest share, driven by strong demand for dietary supplements and functional foods and beverages. Europe holds a significant share, led by Germany, the UK, and France, while Asia Pacific is experiencing rapid growth supported by Japan, China, and South Korea.

Key players vitamin K2  include NattoPharma, Kappa Bioscience, DSM Nutritional Products, Gnosis by Lesaffre, Zhejiang Medicine Co., Ltd., Sports Research Corporation, NOW Foods, MaryRuth Organics, Herbalife Nutrition, Nature's Way, Life Extension, Longlife, Green Valley, and Vital Nutrients. In April 2025, Gnosis by Lesaffre partnered with a leading North American producer of plant-based dairy alternatives to fortify its full portfolio with MenaQ7 Vitamin K2. In November 2024, Balchem Inc. announced the acquisition of a European biotechnology startup focused on chickpea-based fermentation, broadening its non-allergenic, plant-based vitamin K2 solutions.

More Trending Latest Reports By Polaris Market Research:

earphones-and-headphones-market

ai-in-drug-discovery-market

top-5-endobronchial-valve-manufacturers-in-2025

data-center-cooling-market

omega-3-market

glp-drug-market-how-the-obesity-treatment-boom-is-reshaping-global-pharma

alcoholic-beverages-market

contract-research-organization-cro-services-market

biopharma-cold-chain-logistics-market